{"id":"https://openalex.org/W2002992598","doi":"https://doi.org/10.1055/s-2007-1014486","title":"Preference for Alprazolam as Opposed to Diazepam in Benzodiazepine-Dependent Psychiatric Inpatients","display_name":"Preference for Alprazolam as Opposed to Diazepam in Benzodiazepine-Dependent Psychiatric Inpatients","alternate_titles":[],"publication_year":1990,"publication_date":"1990-03-01","ids":{"openalex":"https://openalex.org/W2002992598","doi":"https://doi.org/10.1055/s-2007-1014486","mag":"2002992598","pmid":"https://pubmed.ncbi.nlm.nih.gov/1971118"},"language":"en","primary_location":{"id":"doi:10.1055/s-2007-1014486","doi":"https://doi.org/10.1055/s-2007-1014486","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-1014486","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002992598"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001890531","display_name":"S. Apelt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149899117","display_name":"Max Planck Society","ror":"https://ror.org/01hhn8329","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I149899117"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Apelt","raw_affiliation_strings":["Max Planck Institute for Psychiatry, Munich, FRG","Max Planck Institute of Psychiatry, Max Planck Society"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Max Planck Institute for Psychiatry, Munich, FRG","institution_ids":["https://openalex.org/I4210145969"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Max Planck Society","institution_ids":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072948653","display_name":"Claudia Schmauss","orcid":"https://orcid.org/0000-0002-8523-5110","observed_orcids":["https://orcid.org/0000-0002-8523-5110"]},"institutions":[{"id":"https://openalex.org/I149899117","display_name":"Max Planck Society","ror":"https://ror.org/01hhn8329","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I149899117"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Schmauss","raw_affiliation_strings":["Max Planck Institute for Psychiatry, Munich, FRG","Max Planck Institute of Psychiatry, Max Planck Society"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Max Planck Institute for Psychiatry, Munich, FRG","institution_ids":["https://openalex.org/I4210145969"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Max Planck Society","institution_ids":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109998387","display_name":"H. M. Emrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149899117","display_name":"Max Planck Society","ror":"https://ror.org/01hhn8329","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I149899117"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Emrich","raw_affiliation_strings":["Max Planck Institute for Psychiatry, Munich, FRG","Max Planck Institute of Psychiatry, Max Planck Society"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Max Planck Institute for Psychiatry, Munich, FRG","institution_ids":["https://openalex.org/I4210145969"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Max Planck Society","institution_ids":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4022,"has_fulltext":false,"cited_by_count":12,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.79544789,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"23","issue":"02","first_page":"70","last_page":"75"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.040300000458955765,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.028699999675154686,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":0.9739999771118164},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":1.0},{"id":"https://openalex.org/keywords/benzodiazepine-dependence","display_name":"benzodiazepine dependence","score":0.9929999709129333},{"id":"https://openalex.org/keywords/medication-preferences","display_name":"drug preference","score":0.7829999923706055},{"id":"https://openalex.org/keywords/drug-liking","display_name":"drug liking","score":0.44600000977516174},{"id":"https://openalex.org/keywords/drug-seeking-behavior","display_name":"drug-seeking behavior","score":0.9570000171661377},{"id":"https://openalex.org/keywords/drug-selection","display_name":"drug selection","score":0.6129999756813049},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.7720000147819519},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.7699999809265137},{"id":"https://openalex.org/keywords/psychiatric-inpatients","display_name":"psychiatric inpatients","score":0.7149999737739563},{"id":"https://openalex.org/keywords/reinforcement","display_name":"reinforcement","score":0.30399999022483826},{"id":"https://openalex.org/keywords/withdrawal-symptoms","display_name":"withdrawal symptoms","score":0.40299999713897705},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.4729999899864197},{"id":"https://openalex.org/keywords/relapse-prevention-training","display_name":"relapse prevention training","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.9935675859451294},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.9434586763381958},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.8448305130004883},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.6493706107139587},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5239325165748596},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4663825035095215},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4004727303981781},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38477376103401184},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3746573030948639},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2451116442680359},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.12432113289833069},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1055/s-2007-1014486","doi":"https://doi.org/10.1055/s-2007-1014486","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-1014486","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},{"id":"pmid:1971118","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1971118","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"Clinical Trial"},{"id":"pmh:oai:edoc.mpg.de:572919","doi":null,"is_oa":false,"landing_page_url":"http://edoc.mpg.de/572919","pdf_url":null,"source":{"id":"https://openalex.org/S4406922265","display_name":"Max Planck Institute for Plasma Physics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacopsychiatry, v.23, 70-75 (1990)","raw_type":"Article"},{"id":"pmh:oai:pure.mpg.de:item_1632309","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11858/00-001M-0000-000E-8929-F","pdf_url":null,"source":{"id":"https://openalex.org/S4306400654","display_name":"MPG.PuRe (Max Planck Society)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I149899117","host_organization_name":"Max Planck Society","host_organization_lineage":["https://openalex.org/I149899117"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacopsychiatry","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2418481213","https://openalex.org/W2469097617","https://openalex.org/W1950497346","https://openalex.org/W2130757029","https://openalex.org/W1991144409","https://openalex.org/W2000818284","https://openalex.org/W193291868","https://openalex.org/W54501116","https://openalex.org/W2004831100","https://openalex.org/W1490351910"],"abstract_inverted_index":{"Fourteen":[0],"inpatients":[1],"with":[2,54],"long-term":[3],"benzodiazepine":[4],"(BDZ)-dependency":[5],"were":[6,77],"gradually":[7],"withdrawn":[8],"from":[9],"their":[10],"medication.":[11],"During":[12],"a":[13,106,125],"four-day":[14],"study":[15],"period":[16],"patients":[17,131],"received":[18],"5":[19,29,164,169],"mg":[20,30,38,41,165,170,174,183],"diazepam":[21,31,49,68,76],"t.":[22],"d.":[23],"s.":[24],"Under":[25],"double-blind":[26],"conditions":[27,99],"the":[28,44,80],"was":[32,61,64],"replaced":[33],"twice,":[34],"by":[35],"either":[36],"0.5":[37],"or":[39],"0.37":[40],"alprazolam.":[42],"When":[43,73],"hypothetically":[45],"realistic":[46],"alprazolam":[47,63,74,100,114],"to":[48,56,67,102,116,124,134],"equivalent":[50,82],"ratio":[51,83],"of":[52,84],"1:10":[53,207],"regard":[55],"hypnosedative":[57],"and":[58,75,87,234],"anxiolytic":[59],"properties":[60],"used,":[62],"clearly":[65],"preferred":[66,104],"in":[69,105,129,146,212,250],"three":[70],"sensitive":[71],"tests.":[72],"tested":[78],"using":[79],"altered":[81],"1:14,":[85],"\"liking\"":[86],"\"seeking":[88],"potentials\"":[89],"revealed":[90],"no":[91],"significant":[92],"differences.":[93],"However,":[94],"also":[95],"under":[96],"these":[97],"test":[98],"tended":[101],"be":[103],"drug":[107],"choice":[108],"test.":[109],"It":[110],"is":[111],"concluded":[112],"that":[113],"appears":[115],"implicate":[117],"somewhat":[118],"higher":[119,126],"reinforcing":[120],"properties,":[121],"possibly":[122],"leading":[123],"abuse":[127],"liability":[128],"BDZ-dependent":[130],"as":[132],"compared":[133],"diazepam.":[135],"Zusammenfassung":[136],"14":[137],"Patienten":[138,158,263],"mit":[139,144],"isolierter":[140],"Benzodiazepin":[141],"(BDZ)-Abh\u00e4ngigkeit":[142],"wurden":[143,168],"Diazepam":[145,171,205,211,224,260],"absteigender":[147],"Dosierung":[148],"behandelt.":[149],"W\u00e4hrend":[150],"einer":[151],"4":[152],"Tage":[153],"andauernden":[154],"Studie":[155],"erhielten":[156],"die":[157,232],"unter":[159,225],"Doppelblind-Bedingungen":[160],"t\u00e4glich":[161],"3":[162],"\u00d7":[163],"Diazepam.":[166],"Zweimal":[167],"gegen":[172],"0,5":[173],"Alprazolam":[175,184,203,209,222,249,254],"(Gruppe":[176,185],"1,":[177],"n":[178,187],"=":[179,188],"7)":[180,189],"bzw.":[181],"0,37":[182],"2,":[186],"ausgetauscht.":[190],"Bei":[191,218],"Verwendung":[192],"des":[193],"als":[194],"realistisch":[195],"angenommenen":[196],"\u00c4quivalenzverh\u00e4ltnisses":[197],"hinsichtlich":[198],"der":[199],"hypno-sedativ-anxiolytischen":[200],"Wirkung":[201],"von":[202,206,221,229,248],"zu":[204,259],"wurde":[208],"gegen\u00fcber":[210],"drei":[213],"sensitiven":[214],"Tests":[215],"eindeutig":[216],"bevorzugt.":[217],"dem":[219,251],"Vergleich":[220,258],"und":[223],"einem":[226],"ver\u00e4nderten":[227],"\u00c4quivalenzverh\u00e4ltnis":[228],"1:14":[230],"zeigten":[231],",,Liking-\"":[233],",,Seeking\"-Daten":[235],"keine":[236],"signifikanten":[237],"Unterschiede.":[238],"Allerdings":[239],"zeigte":[240],"sich":[241],"auch":[242],"hier":[243],"eine":[244],"Tendenz":[245],"zur":[246],"Bevorzugung":[247],",,drugchoice\"-":[252],"Test.":[253],"scheint":[255],"somit":[256],"im":[257],"bei":[261],"BDZ-abh\u00e4ngigen":[262],"ein":[264],"etwas":[265],"h\u00f6heres":[266],"Suchtpotential":[267],"aufzuweisen.":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002992598","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
